
The Conversation Weekly The 40 scientists who decide which flu shot you'll get
13 snips
Nov 27, 2025 Ian Barr, a leading virologist and Deputy Director at the WHO Collaborating Centre for Reference and Research on Influenza, reveals the intricate process behind flu vaccine strain selection. He shares insights on how 40 scientists meet biannually to decide which strains to target, the role of hemispheric interactions in flu patterns, and how emerging variants complicate decisions. Barr also discusses the future of vaccines, including advancements in mRNA technology, and addresses the rise of vaccine hesitancy post-COVID.
AI Snips
Chapters
Transcript
Episode notes
Global Panel Makes Twice-Yearly Vaccine Calls
- Forty experts meet twice yearly to analyse global data, discuss zoonotic spillovers and produce rationale documents for vaccine changes.
- The WHO Collaborating Centres and industry convene to explain recommendations to vaccine producers on the meeting's final day.
Flu Shots Now Target Three Strains
- Current vaccines contain three strains: two influenza A (H1 and H3) plus one influenza B lineage.
- Since 2023 the WHO has recommended trivalent vaccines instead of the previous four-strain formulation.
Strain Selection Is Crystal-Ball Work
- Decisions involve uncertainty because samples arrive with delays and viruses can emerge and spread rapidly.
- Ian Barr said making predictions six to nine months ahead is difficult and often involves debate among experts.
